pmc logo image
Logo of jclinpathJournal of Clinical PathologyCurrent TOCInstructions for authors

Formats:

J Clin Pathol. 1993 August; 46(8): 738–741.
PMCID: PMC501460
Benign familial hyperphosphatasaemia as a cause of unexplained increase in plasma alkaline phosphatase activity.
S B Rosalki, A Y Foo, and J S Dooley
Department of Chemical Pathology and Human Metabolism, Royal Free Hospital and School of Medicine, London.
Abstract
AIMS--To consider a possible genetic origin for the persistent unexplained increase in plasma alkaline phosphatase (ALP) in five non-related patients referred over an 18 month period. METHODS--Plasma ALP isoenzyme activities were measured in patients and their first degree relatives. RESULTS--In each patient there was a noticeable increase in intestinal plasma ALP, either alone or accompanied by an increase in bone or liver ALP. Family studies showed an unexpected increase in plasma ALP and similar isoenzyme changes in first degree relatives. The findings were consistent with autosomal dominant inheritance. CONCLUSION--Inherited raised plasma ALP activity is a reasonably common cause of persistent unexplained hyperphosphatasaemia which deserves wider recognition.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (873K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • De Broe ME, Bosteels V, Wieme RJ. Letter: Increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis. Lancet. 1974 Apr 20;1(7860):753–754. [PubMed]
  • Wilson JW. Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med. 1979 Nov 1;301(18):983–984. [PubMed]
  • Tietz NW, Rinker AD, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem. 1983 Nov;21(11):731–748. [PubMed]
  • Rosalki SB, Foo AY. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984 Jul;30(7):1182–1186. [PubMed]
  • Van Hoof VO, Lepoutre LG, Hoylaerts MF, Chevigné R, De Broe ME. Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin Chem. 1988 Sep;34(9):1857–1862. [PubMed]
  • Kuwana T, Rosalki SB. Intestinal variant alkaline phosphatase in plasma in disease. Clin Chem. 1990 Nov;36(11):1918–1921. [PubMed]
  • Hosenfeld D, Lehmann W, Pálsson J, Frants R. A rare electrophoretic enzyme variant of serum alkaline phosphatase in a group of Icelanders. Hum Hered. 1979;29(5):298–305. [PubMed]
  • Parker PH, Ghishan FK. Asymptomatic familial elevation of serum alkaline phosphatase levels. Am J Dis Child. 1980 Nov;134(11):1094–1095. [PubMed]
  • Cirera Nogueras L, Vivancos Lleida J, Salazar Badia M, Ercilla Gonzalez G, Ballesta Martinez F, Martin Vega C, Carbonell Abello J. Raised serum alkaline phosphatase activity in one family. Arch Intern Med. 1982 Jan;142(1):188–189. [PubMed]
  • Kruse K. Inherited isolated hyperphosphatasemia. Acta Paediatr Scand. 1983 Nov;72(6):833–835. [PubMed]
  • Rapado A, Esbrit P. Hiperfosfatasia asintomática familiar por elevación de la isoenzima intestinal. Rev Clin Esp. 1984 Apr 15;173(1):53–54. [PubMed]
  • Abbassi V, Colon AR, Schwartz RH. Benign elevation of serum alkaline phosphatase, transient and persistent variety. Clin Pediatr (Phila). 1984 Jun;23(6):336–337. [PubMed]
  • Kruse K. Normal bone turnover in isolated hyperphosphatasemia. J Pediatr. 1985 Jun;106(6):946–948. [PubMed]
  • Lewis JM. Persistent isolated hyperphosphatasemia. South Med J. 1987 Jun;80(6):788–790. [PubMed]
  • Rico H, Martínez F, Romero P, Casimiro C. Hiperfosfatasemia familiar benigna: a propósito de una observación. Rev Clin Esp. 1987 May;180(8):465–466. [PubMed]
  • Siraganian PA, Mulvihill JJ, Mulivor RA, Miller RW. Benign familial hyperphosphatasemia. JAMA. 1989 Mar 3;261(9):1310–1312. [PubMed]
  • Onica D, Rosendahl K, Waldenlind L. Inherited occurrence of a heat stable alkaline phosphatase in the absence of malignant disease. Clin Chim Acta. 1989 Mar 15;180(1):23–34. [PubMed]
  • Onica D, Rosendahl K, Waldenlind L. Further characterization of a heat-stable alkaline phosphatase with low sensitivity to L-phenylalanine. Clin Chim Acta. 1990 Dec 24;194(2-3):193–202. [PubMed]
  • Lieverse AG, van Essen GG, Beukeveld GJ, Gazendam J, Dompeling EC, ten Kate LP, van Belle SA, Weits J. Familial increased serum intestinal alkaline phosphatase: a new variant associated with Gilbert's syndrome. J Clin Pathol. 1990 Feb;43(2):125–128. [PubMed]
  • Swallow DM, Povey S, Parkar M, Andrews PW, Harris H, Pym B, Goodfellow P. Mapping of the gene coding for the human liver/bone/kidney isozyme of alkaline phosphatase to chromosome 1. Ann Hum Genet. 1986 Jul;50(Pt 3):229–235. [PubMed]
  • Henthorn PS, Raducha M, Kadesch T, Weiss MJ, Harris H. Sequence and characterization of the human intestinal alkaline phosphatase gene. J Biol Chem. 1988 Aug 25;263(24):12011–12019. [PubMed]
  • Martin D, Tucker DF, Gorman P, Sheer D, Spurr NK, Trowsdale J. The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37. Ann Hum Genet. 1987 May;51(Pt 2):145–152. [PubMed]
  • Bentouati L, Baboli MS, Hachem H, Hamza M, Canal P, Soula G. Hyperphosphatasemia related to three intestinal alkaline phosphatase isoforms: biochemical study. Clin Chim Acta. 1990 Dec 13;193(1-2):93–102. [PubMed]
  • Kricka LJ, Wilding P, Long WB, Mulivor RA. Benign hyperphosphatasemia. Clin Chem. 1990 Feb;36(2):389. [PubMed]